Efficacy of Buspirone Augmentation of Escitalopram in Patients with Major Depressive Disorder with and without Atypical Features: A Randomized, 8 Week, Multicenter, Open-Label Clinical Trial.

Shin, Cheolmin; Ko, Young-Hoon; Shim, Se-Hoon; Kim, Ji Sun; Na, Kyoung-Sae; Hahn, Sang-Woo; Lee, Seung-Hwan

Shin, Cheolmin; Ko, Young-Hoon; Shim, Se-Hoon; Kim, Ji Sun; Na, Kyoung-Sae; Hahn, Sang-Woo; Lee, Seung-Hwan.

Afiliação

Shin C; Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
Ko YH; Department of Psychiatry, Korea University College of Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.
Shim SH; Department of Psychiatry, Soonchunhyang University College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
Kim JS; Department of Psychiatry, Soonchunhyang University College of Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea.
Na KS; Department of Psychiatry, Gachon University College of Medicine, Gil Medical Center, Incheon, Republic of Korea.
Hahn SW; Department of Psychiatry, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
Lee SH; Department of Psychiatry, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.

Psychiatry Investig ; 17(8): 796-803, 2020 Aug.

Article em En | MEDLINE | ID: mdl-32750760